0001062993-23-006334.txt : 20230308
0001062993-23-006334.hdr.sgml : 20230308
20230308200654
ACCESSION NUMBER: 0001062993-23-006334
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230306
FILED AS OF DATE: 20230308
DATE AS OF CHANGE: 20230308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HERSHBERG ROBERT
CENTRAL INDEX KEY: 0001274139
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38957
FILM NUMBER: 23717824
MAIL ADDRESS:
STREET 1: 3005 FIRST AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adaptive Biotechnologies Corp
CENTRAL INDEX KEY: 0001478320
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270907024
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1165 EASTLAKE AVE E
CITY: SEATTLE
STATE: WA
ZIP: 98109
BUSINESS PHONE: 206-659-0067
MAIL ADDRESS:
STREET 1: 1165 EASTLAKE AVE E
CITY: SEATTLE
STATE: WA
ZIP: 98109
FORMER COMPANY:
FORMER CONFORMED NAME: Adaptive TCR Corp
DATE OF NAME CHANGE: 20091209
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2023-03-06
0001478320
Adaptive Biotechnologies Corp
ADPT
0001274139
HERSHBERG ROBERT
C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION
1165 EASTLAKE AVENUE EAST
SEATTLE
WA
98109
1
0
0
0
Common Stock
2023-03-06
4
A
0
14775
0
A
75968
D
Stock Option (right to buy)
8.46
2023-03-06
4
A
0
23329
0
A
2033-03-06
Common Stock
23329
23329
D
The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates.
/s/ Robert Hershberg by Stacy L Taylor, Attorney-in-Fact
2023-03-08